Stockreport

Acorda Provides Update for Second Quarter Ended June 30, 2019

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF INBRIJA™ (levodopa inhalation powder) 2Q 2019 net sales of $3.0 millionCHMP issues positive opinion on INBRIJAAMPYRA® (dalfampridine) 2Q 2019 net sales of $44.0 million [Read more]